Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Tadalafil × Clear all

NCT05558007 2024-10-22

Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients

Phase 2 Recruiting

Erectile Dysfunction, Prostatic Neoplasms